583 related articles for article (PubMed ID: 8776360)
21. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
Leer JA
Clin Ther; 1980; 3(3):156-67. PubMed ID: 7006810
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
23. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
[TBL] [Abstract][Full Text] [Related]
24. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
[TBL] [Abstract][Full Text] [Related]
25. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
[TBL] [Abstract][Full Text] [Related]
26. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
Lebwohl MG; Tan MH; Meador SL; Singer G
J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
[TBL] [Abstract][Full Text] [Related]
27. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
28. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
Sharma SD
Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
[No Abstract] [Full Text] [Related]
29. Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
Malfitan VA
Clin Ther; 1983; 5(3):290-8. PubMed ID: 6850723
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study.
Erceg A; Bovenschen HJ; van de Kerkhof PC; Seyger MM
Br J Dermatol; 2006 Jul; 155(1):110-4. PubMed ID: 16792761
[TBL] [Abstract][Full Text] [Related]
31. Microcirculatory modifications of psoriatic lesions during topical therapy.
Rosina P; Giovannini A; Gisondi P; Girolomoni G
Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121
[TBL] [Abstract][Full Text] [Related]
32. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage.
Rafal ES; Griffiths CE; Ditre CM; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
N Engl J Med; 1992 Feb; 326(6):368-74. PubMed ID: 1729619
[TBL] [Abstract][Full Text] [Related]
33. Problems in selection of topical anti-inflammatory corticosteroids.
Stewart WD; Runikis JO; Verma SC; Wallace S
Can Med Assoc J; 1973 Jan; 108(1):33-8. PubMed ID: 4682636
[TBL] [Abstract][Full Text] [Related]
34. Treatment of psoriasis with topically applied tretinoin and steroid ointment.
Kaidbey KH; Petrozzi JW; Kligman AM
Arch Dermatol; 1975 Aug; 111(8):1001-3. PubMed ID: 786170
[TBL] [Abstract][Full Text] [Related]
35. Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
[TBL] [Abstract][Full Text] [Related]
36. In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining.
Zulfakar MH; Alex A; Povazay B; Drexler W; Thomas CP; Porter RM; Heard CM
Exp Dermatol; 2011 Mar; 20(3):269-72. PubMed ID: 21323746
[TBL] [Abstract][Full Text] [Related]
37. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
[TBL] [Abstract][Full Text] [Related]
38. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
40. Effects of tretinoin on photodamaged skin. A histologic study.
Bhawan J; Gonzalez-Serva A; Nehal K; Labadie R; Lufrano L; Thorne EG; Gilchrest BA
Arch Dermatol; 1991 May; 127(5):666-72. PubMed ID: 2024984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
